ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Clinton Backs Ban On Human Cloning; Wisconsin Selects Niederhuber As Director

June 13, 1997

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

Hammer Says President’s Science Advisory to Ask For FY 1985 Supplemental Appropriations for NCI

March 1, 1985

Solomon Gard Loses Final Cancer Battle

February 12, 1982

Roswell Park Wins Competition for Organ Systems Coordinating Center

May 18, 1984